Clinical Study On Bharangi Sarkara In Patients With Tamaka Shwasa(Bornchial Asthma)

A Randomized Controlled Trial To Evaluate The Effect Of Bharangi Sarkara In Tamaka Shwasa W.S.R To Bronchial Asthma - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/074611

Enrollment

Registered

2024-10-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients fulfilling the diagnostic criteria. 2. Age eligibility for the study- 18 years to 70 years. 3. Mild intermittent, Mild persistent, Moderate persistent cases of Bronchial Asthma according to GINA guidelines for Asthma

Exclusion criteria

Exclusion criteria: 1. Severe persisting Asthma according to Global Initiative for Asthma (GINA) guidelines. 2. Patient with history of congenital anatomical abnormalities of chest and respiratory system. 3. Subjects with uncontrolled diabetes mellitus were excluded (RBS more than 300 mg/dl) 4. Other systemic disorders which intervene the treatment. 5. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
1. Teevra Vega Shwasa - Shwasa Krichrata (Dyspnoea) 2. Dukhena Kapha nissaranam (Expectoration) 3. Ghurghuratwam (Wheezing) 4. Kasa (Cough)Timepoint: 30 days	—

Secondary

Measure	Time frame
1. Changes in Peak Flow Meter Test values 2. Chest Expansion (in centimeters): during inspiration and expiration 3. Sputum: Scanty/Moderate/ProfuseTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDR JYOTHSNAA K

Sri Dharmasthala Manjunatheshwara College of Ayurveda, Hospital and Research Centre,Kuthpady

khadiravana@gmail.com9743490753

Outcome results